Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Novartis Adds $375 Million in China Investments

publication date: Nov 4, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Novartis continued its mega-investments in China by announcing it will spend $250 million to expand its global technical center in Changshu, and it will also pay $125 million to buy a 85% stake in a privately held China vaccine company, Zhejiang Tianyuan. Yesterday, Novartis said it would spend $1 billion over the next five years to expand its R&D facility in Shanghai, one of the institutions around the world that comprise the Novartis Institutes for BioMedical Research (NIBR). More details...

Stock Symbol: (NYSE: NVS)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners